fda approved glp 1 pill Orforglipron Oral GLP-1 by FDA Approves First ORAL GLP-1

D., Sanyal, A

Each of the three pathways contributes different effects: GI Side Effects (Primarily from GLP-1) The GLP-1 component is responsible for most gastrointestinal side effects because it slows gastric emptying and affects gut motility: Metabolic Effects (From Glucagon Component) The glucagon component may cause slight increases in: Heart rate: Average increase of 5-10 bpm due to increased metabolic rate (similar to tirzepatide) Body temperature: Some users report feeling warmer, especially after meals (thermogenesis) Energy levels: Variable

Nausea, vomiting, constipation, and diarrhea are most common

Some users find they respond well to lower doses and never need to reach the peak phase amounts